These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 9458167)

  • 1. Glial-neuronal interactions in Alzheimer's disease: the potential role of a 'cytokine cycle' in disease progression.
    Griffin WS; Sheng JG; Royston MC; Gentleman SM; McKenzie JE; Graham DI; Roberts GW; Mrak RE
    Brain Pathol; 1998 Jan; 8(1):65-72. PubMed ID: 9458167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cytokines in Alzheimer's disease: review and pathogenic implications.
    Mrak RE; Sheng JG; Griffin WS
    Hum Pathol; 1995 Aug; 26(8):816-23. PubMed ID: 7635444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of chronic self-propagating glial responses in neurodegeneration: implications for long-lived survivors of human immunodeficiency virus.
    Mrak RE; Griffin WS
    J Neurovirol; 1997 Aug; 3(4):241-6. PubMed ID: 9291232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease.
    Mrak RE; Griffinbc WS
    Neurobiol Aging; 2001; 22(6):915-22. PubMed ID: 11754999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deleterious Alteration of Glia in the Brain of Alzheimer's Disease.
    Kim E; Otgontenger U; Jamsranjav A; Kim SS
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo.
    Craft JM; Watterson DM; Frautschy SA; Van Eldik LJ
    Neurobiol Aging; 2004; 25(10):1283-92. PubMed ID: 15465624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glia and their cytokines in progression of neurodegeneration.
    Mrak RE; Griffin WS
    Neurobiol Aging; 2005 Mar; 26(3):349-54. PubMed ID: 15639313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives in Pain Research 2014: Neuroinflammation and glial cell activation: The cause of transition from acute to chronic pain?
    Cairns BE; Arendt-Nielsen L; Sacerdote P
    Scand J Pain; 2015 Jan; 6(1):3-6. PubMed ID: 29911589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.
    Lian H; Zheng H
    J Neurochem; 2016 Feb; 136(3):475-91. PubMed ID: 26546579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review.
    Mrak RE; Griffin WS
    EOS; 1996; 16(3-4):80-84. PubMed ID: 24478534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
    Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
    J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuron-glia interactions as therapeutic targets in neurodegeneration.
    Salmina AB
    J Alzheimers Dis; 2009; 16(3):485-502. PubMed ID: 19276541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease.
    Al-Ghraiybah NF; Wang J; Alkhalifa AE; Roberts AB; Raj R; Yang E; Kaddoumi A
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pro-inflammatory cytokines in Alzheimer's disease].
    Stamouli EC; Politis AM
    Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of Astrocyte-Neuronal Communication in Alzheimer's Disease.
    Nanclares C; Baraibar AM; Araque A; Kofuji P
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease.
    Afkhami-Goli A; Noorbakhsh F; Keller AJ; Vergnolle N; Westaway D; Jhamandas JH; Andrade-Gordon P; Hollenberg MD; Arab H; Dyck RH; Power C
    J Immunol; 2007 Oct; 179(8):5493-503. PubMed ID: 17911636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.
    Mrak RE; Sheng JG; Griffin WS
    J Neuropathol Exp Neurol; 1996 Mar; 55(3):273-9. PubMed ID: 8786385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cell dysregulation: a new perspective on Alzheimer disease.
    von Bernhardi R
    Neurotox Res; 2007 Dec; 12(4):215-32. PubMed ID: 18201950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease.
    Stanley LC; Mrak RE; Woody RC; Perrot LJ; Zhang S; Marshak DR; Nelson SJ; Griffin WS
    J Neuropathol Exp Neurol; 1994 May; 53(3):231-8. PubMed ID: 8176406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.